Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute

Funding Agency:
National Institutes of Health

This NOSI from the NCI expresses continued interest in receiving Career Development Award applications from early career scientists conducting research within the mission of the Division of Cancer Prevention.

The Division of Cancer Prevention (DCP) at the National Cancer Institute (NCI) supports research that adances the application of the mechanistic and scientific understanding of carcinogenesis and human biology towards interventions focused on cancer prevention, interception, screening and early detection, and symptom management. These mechanistic understandings can come from research conducted across basic science, epidemiology, behavioral, or clinical studies and by varied scientific disciplines. DCP also supports research spanning the full translational spectrum, from preclinical (e.g., cell and tissue culture, animal models) to clinical (e.g., small early phase clinical trials to large phase three studies) research. Key to advancing the work of DCP and developing successful interventions is having a robust workforce trained in translational cancer prevention research, including cancer interception, screening and early detection, and symptom science strategies and methods.

To this end, the NCI Cancer Training Branch in the Center for Cancer Training, Diversity Training Branch in the Center to Reduce Cancer Health Disparities, and DCP are issuing this announcement to stimulate applications from early-career scientists conducting research within the mission of DCP to existing career development funding opportunities.

This notice applies to due dates on or after February 12, 2023, and subsequent receipt dates through November 13, 2024.

NOT-CA-23-035

 

Eligibility

Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

June 12, 2024